These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23647828)

  • 21. Completeness of a newly implemented general cancer registry in northern France: Application of a three-source capture-recapture method.
    Plouvier SD; Bernillon P; Ligier K; Theis D; Miquel PH; Pasquier D; Rivest LP
    Rev Epidemiol Sante Publique; 2019 Jul; 67(4):239-245. PubMed ID: 31146902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
    AIRTUM Working Group
    Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coverage, density and completeness of sources used in Tehran Metropolitan Area Cancer Registry: according to the data of esophageal cancer, 2003-2007.
    Aghaei A; Najaf F; Mosavi-Jarrahi A; Ahmadi-Jouibari T
    Asian Pac J Cancer Prev; 2012; 13(8):3617-9. PubMed ID: 23098443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an online cancer data collection and processing tool for population-based cancer registries in a low-resource setting: The CanDCap experience from Golestan, Iran.
    Hasanpour-Heidari S; Ahmadi A; Mansuri S; Qorbani A; Semnani S; Fazel A; Sedaghat S; Sadeghzadeh H; Roshanpoor A; Langarizadeh M; Weiderpass E; Roshandel G
    Int J Med Inform; 2022 Oct; 166():104846. PubMed ID: 35981480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The completeness and timeliness of cancer registration and the implications for measuring cancer burden.
    Donnelly C; Cairnduff V; Chen JJ; Kearney T; Fitzpatrick D; Fox C; Gavin A
    Cancer Epidemiol; 2017 Aug; 49():101-107. PubMed ID: 28600946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges to promoting population-based cancer registration in Iran: a workshop report.
    Hadji M; Nahvijou A; Seddighi Z; Beiki O; Mohagheghi MA; Mosavi-Jarrahi A; Marnani AB; Zendehdel K
    Asian Pac J Cancer Prev; 2013; 14(10):6189-93. PubMed ID: 24289647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries.
    Larsen H; Nielsen GL; Bendsen J; Flint C; Olsen J; Sørensen HT
    Scand J Public Health; 2003; 31(1):12-6. PubMed ID: 12623519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and Incidence of Multiple Sclerosis in Fars Province, Southern Iran.
    Izadi S; Nikseresht AR; Poursadeghfard M; Borhanihaghighi A; Heydari ST
    Iran J Med Sci; 2015 Sep; 40(5):390-5. PubMed ID: 26379344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer incidence in the East Azerbaijan province of Iran in 2015-2016: results of a population-based cancer registry.
    Somi MH; Dolatkhah R; Sepahi S; Belalzadeh M; Sharbafi J; Abdollahi L; Nahvijou A; Nemati S; Malekzadeh R; Zendehdel K
    BMC Public Health; 2018 Nov; 18(1):1266. PubMed ID: 30453968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of cancer registration and cancer data in Iran, a historical prospect.
    Ali Mohagheghi M; Mosavi-Jarrahi A
    Asian Pac J Cancer Prev; 2010; 11(4):1155-7. PubMed ID: 21133641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.
    Sigurdardottir LG; Jonasson JG; Stefansdottir S; Jonsdottir A; Olafsdottir GH; Olafsdottir EJ; Tryggvadottir L
    Acta Oncol; 2012 Sep; 51(7):880-9. PubMed ID: 22974093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimation of cancer cases using capture-recapture method in Northwest Iran.
    Ghojazadeh M; Mohammadi M; Azami-Aghdash S; Sadighi A; Piri R; Naghavi-Behzad M
    Asian Pac J Cancer Prev; 2013; 14(5):3237-41. PubMed ID: 23803110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appropriateness of Congenital Hypothyroidism Screening Program in Fars Province, Iran: A Retrospective Study from 2005 to 2015.
    Shaghaghian S; Rahimi N; Mousavi-Roknabadi RS; Azadian F; Nazemzadegan B; Ghasempour H; Moghadami M; Keshavarz S
    Iran J Med Sci; 2019 May; 44(3):245-250. PubMed ID: 31182891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new method to evaluate the completeness of case ascertainment by a cancer registry.
    Das B; Clegg LX; Feuer EJ; Pickle LW
    Cancer Causes Control; 2008 Jun; 19(5):515-25. PubMed ID: 18270798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Innovative Approach to Improve Completeness of Treatment and Other Key Data Elements in a Population-Based Cancer Registry: A15-Month Data Submission.
    Hsieh MC; Mumphrey B; Pareti L; Yi Y; Wu XC
    J Registry Manag; 2017; 44(2):69-75. PubMed ID: 29611688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Elements of completeness and results of the first year of registration of the "Registre général des cancers de Lille et de sa région"].
    Ligier K; Plouvier S; Danzon A; Martin P; Benoît E; Molinié F; Launoy G; Buisset E; Leroy X; Chevalier D; Chaud P; Chérié-Challine L
    Rev Epidemiol Sante Publique; 2012 Apr; 60(2):131-9. PubMed ID: 22424751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIDS and cancer registry linkage: measurement and enhancement of registry completeness. The National AIDS/Cancer Match Study Group.
    Coté TR; O'Brien TR; Ward JW; Wilson SE; Blattner WA
    Prev Med; 1995 Jul; 24(4):375-7. PubMed ID: 7479628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bayesian spatial modeling of transfusion-dependent β-thalassemia incidence rate in Fars Province, Southern Iran.
    Haghpanah S; Asmarian N; Zekavat OR; Bordbar M; Karimi M; Zareifar S; Ramzi M; Safaei S
    Spat Spatiotemporal Epidemiol; 2021 Feb; 36():100389. PubMed ID: 33509421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Cancer Registry of the Islamic Republic of Iran: Steps for Establishment and Results of the Pilot Phase.
    Seyyedsalehi MS; Nahvijou A; Rouhollahi M; Teymouri F; Mirjomehri L; Zendehdel K
    J Registry Manag; 2020; 47(4):200-206. PubMed ID: 34170898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Data quality at the Bulgarian National Cancer Registry: An overview of comparability, completeness, validity and timeliness.
    Dimitrova N; Parkin DM
    Cancer Epidemiol; 2015 Jun; 39(3):405-13. PubMed ID: 25914137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.